MENDLEIN JOHN 4
4 · FATE THERAPEUTICS INC · Filed Jun 4, 2021
Insider Transaction Report
Form 4
MENDLEIN JOHN
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-02+4,334→ 4,334 totalExercise: $68.94Exp: 2031-06-01→ Common Stock (4,334 underlying) - Award
Common Stock
2021-06-02+2,681→ 159,455 total
Footnotes (2)
- [F1]Award of restricted stock units that vest in full on the earlier of (i) June 2, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
- [F2]The shares subject to this option shall vest and become exercisable on the earlier of (i) June 2, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.